Joo-Yun Byun

3PUBLICATIONS
10CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Feb 27, 2025
Retraction Note: Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma.

Joo-Yun Byun, Kun Huang, Jong Suk Lee

|Dec 12, 2024
Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia.

Himangshu Sonowal, William G Rice, Raphael Bejar

|Jan 11, 2022
Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma.

Joo-Yun Byun, Kun Huang, Jong Suk Lee

Pageof 1

Frequent Collaborators

2 joint publications

Jong Suk Lee

2 joint publications

Dong-Gyu Jo

2 joint publications

Xinmao Song

2 joint publications

Chuang Huang

1 joint publications

Himangshu Sonowal

1 joint publications

William G Rice

1 joint publications

Raphael Bejar

1 joint publications

Seung Hyun Jung

1 joint publications

Ranjeet Sinha

1 joint publications

Stephen B Howell

Frequent Collaborators

2 joint publications

Jong Suk Lee

2 joint publications

Dong-Gyu Jo

2 joint publications

Xinmao Song

2 joint publications

Chuang Huang

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

1.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

994
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on : May 11, 2016

8.6K
See more related videos

Top Related Videos

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

1.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

994
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on : May 11, 2016

8.6K
See more related videos